BREEZER MOBILE COOLING TO HIT HAWAII AT LANPAC 2018

LANPAC 2018 is coming up on May 22-24, and Breezer Mobile Cooling is excited to attend! This world-class international event will be held at the Sheraton Waikiki Hotel in Honolulu, HI. It will highlight the role of land forces in the Indo-Asia-Pacific theater and their contributions to the Joint Force in both peacetime and war. The Association of the United States Army’s Institute of Land Warfare and the U.S. Army Pacific and U.S. Pacific Command are presenting this year’s show. Mike Yoakum, CMSgt (USAF Ret) Director of Government National Strategic Accounts expressed his excitement over attending: “We come out here to Hawaii every year in support of this great show. It’s a terrific opportunity to connect with industry, active military and local DoD, all focused on the Indo-Asia Pacific area.”

WHY ATTEND?

More than 1500 attendees will be at LANPAC 2018. These participants will be coming from places domestic and foreign, from different military ranks, and from various branches. In addition, participants will enjoy presentations from key leaders and embrace a whole-government approach to national security. With an exhibit hall and hands-on demonstrations, professional learning opportunities are plentiful. At LANPAC 2018, attendees can also network with other professionals in a tropical venue while sharing about issues related to a variety of military operations.

EMBRACING THE U.S. ARMED FORCES

Breezer Mobile Cooling has a history of strong support for U.S. soldiers. Brian Williams, MSG (US Army Reserves) is our Regional Business Development Manager. He described Breezer Mobile Cooling’s commitment, stating, “Our rugged cooling fans make such a difference for the soldiers. Especially in the Indo-Asia Pacific area with high heat and humidity. They face so many threats. Heat should not be one of them.” Our products are designed and assembled in the U.S.A. and a large percentage of our workforce is veterans. And because those protecting us need protection from extreme temperatures, we designed our mobile cooling products to be durable and tough. They reduce mistakes, increase productivity, while creating safe work environments and keep mission readiness high. 

CONNECT AT LANPAC

We invite you to come by our booth L13 and learn about the cooling solutions powerful enough to be military-strong. You face enough threats. Don’t let heat be one of them.

Learn more about Breezer Mobile Cooling solutions here.

Read more at powerbreezer.com

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More